KO
60
-3
TSN
38
-2
IPG
31
-12
GME
91
8
FITB
56
-2
ZTS
33
2
GD
49
-3
PPL
67
-2
AIV
41
-2
VIX
49
-5
DIS
64
2
VMC
65
-10
KEY
60
2
UAL
48
-3
GT
45
7
CSX
33
2
CB
47
-4
AON
49
-3
SBUX
43
4
ETR
69
-5
KO
60
-3
TSN
38
-2
IPG
31
-12
GME
91
8
FITB
56
-2
ZTS
33
2
GD
49
-3
PPL
67
-2
AIV
41
-2
VIX
49
-5
DIS
64
2
VMC
65
-10
KEY
60
2
UAL
48
-3
GT
45
7
CSX
33
2
CB
47
-4
AON
49
-3
SBUX
43
4
ETR
69
-5
Financhill
Back

NovoCure Stock Price Chart

Your Portfolio's Boring. This Company Isn't And It's Early

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
38

NVCR
NovoCure

Last Price:
$18.55
Seasonality Move:
11%

7 Day Trial

ALL ACCESS PASS

$ 7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight buying pressure.

NovoCure Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 17.84 Buy
20-day SMA: 17.81 Buy
50-day SMA: 17.77 Buy
200-day SMA: 20.26 Sell
8-day EMA: 17.88 Buy
20-day EMA: 17.73 Buy
50-day EMA: 18.33 Sell
200-day EMA: 20.25 Sell

NovoCure Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 52.86 Buy
Chaikin Money Flow: 396869 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.77 - 18.45) Buy
Bollinger Bands (100): (16.77 - 25.51) Sell

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for NovoCure Stock

Is NovoCure Stock a Buy?

  • NovoCure share price is 18.11 while NVCR 8-day simple moving average is 17.84, which is a Buy signal.
  • The stock price of NVCR is 18.11 while NovoCure 20-day SMA is 17.81, which makes it a Buy.
  • NovoCure 50-day simple moving average is 17.77 while NVCR share price is 18.11, making it a Buy technically.
  • NVCR stock price is 18.11 and NovoCure 200-day simple moving average is 20.26, creating a Sell signal.

NVCR Technical Analysis vs Fundamental Analysis

Sell
38
NovoCure (NVCR) is a Sell

Is NovoCure a Buy or a Sell?

  • NovoCure stock is rated a Sell
    The current NovoCure [NVCR] share price is $18.11. The Score for NVCR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.

NovoCure Stock Info

Market Cap:
2B
Price in USD:
18.11
Share Volume:
885.3K

NovoCure 52-Week Range

52-Week High:
34.13
52-Week Low:
14.17
Sell
38
NovoCure (NVCR) is a Sell

NovoCure Share Price Forecast

  • What is the NovoCure stock price today?
    The NovoCure stock price is 18.11 USD today.
  • Will NVCR stock go up or go down?
    NovoCure> share price is forecast to RISE/FALL based on technical indicators
  • Is NovoCure overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is overvalued.

Is NovoCure Stock a Buy?

  • NovoCure share price is 18.11 while NVCR 8-day exponential moving average is 17.88, which is a Buy signal.
  • The stock price of NVCR is 18.11 while NovoCure 20-day EMA is 17.73, which makes it a Buy.
  • NovoCure 50-day exponential moving average is 18.33 while NVCR share price is 18.11, making it a Sell technically.
  • NVCR stock price is 18.11 and NovoCure 200-day simple moving average is 20.25, creating a Sell signal.

Fundamental Analysis of NovoCure

Is NovoCure a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.10 per share.

Technical Analysis of NovoCure

Should I short NovoCure stock?

  • NVCR Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting NovoCure is a Buy
  • NovoCure Relative Strength Index (RSI) is 52.86, which suggest NovoCure is overbought
  • The Bollinger Bands (25) for NovoCure is (16.77 - 18.45), which suggest NovoCure is a Sell
  • The Bollinger Bands (100) for NovoCure is (16.77 - 25.51), which suggest NovoCure is a Sell

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.